Skip to main content
Equibles
AIDX logo

AIDX · 20/20 Biolabs, Inc.

Track AIDX — free

Use AIDX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AIDX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.55 +0.04 (+7.82%) At close · Aug 21
Market Cap
$6.57M
Shares
12.77M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.55 Open$0.52 Day$0.50–0.64 Available close range$0.40–23.85 Avg vol 30d115K Short int153K · 1.2% float · 1.3d Short vol23% DataFeb 2026–Aug 2026 Filing10-Q · Aug 14

The closing range uses available history since Feb 19, 2026; less than a full year is stored.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 14, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Weak Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.1 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 50-day avg +1%
above
RSI (14) 55
neutral
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +13%
trailing
6-month return −84%
trailing
Relative strength −95%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+114% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.20% of float · ▼ -38.3% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
15 holders — 13F breadth
Squeeze score 34
low risk · 0–100
Fundamentals
Excellent
Revenue growth +17%
Y/Y
Gross margin 30%
expanding
EPS growth +34%
Y/Y
Balance sheet $1.0M
net cash
Quant / Vol
risk profile
Very High
Volatility 142%
annualized · 1-yr
Max drawdown −98%
past year
ATR 10.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
+1% Bullish
RSI (14)
55 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+114% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.20% of float · ▼ -38.3% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
15 holders — 13F breadth
Price context
position in its available closing range
Range low $0 Now $1 · 1% Range high $24
vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
OneTest™ accounting for 95.3% Q2 2026 —
orders from new accounts 29 the second quarter —
Deferred revenue $0.4M FY 2025 —
Increase in OneTest MCEDs funded through Maryland program 225% FY 2025 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AIDX
20/20 Biolabs, Inc.
this stock
$6.57M — +16.7% — 1.2%
ABT
Abbott Laboratories
 $198.81B -6.9% +5.7% 32.0 1.3%
SYK
Stryker Corp
 $126.37B -6.3% +11.2% 34.1 2.2%
MDT
Medtronic plc
 $119.47B -2.8% +8.4% 25.0 1.4%
BSX
Boston Scientific Corp
 $71.55B -47.2% +12.5% 20.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
15
% held
4.2%
Net QoQ
+240.2K sh
Top holder
Cresset Asset Management,…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
153.3K
Days to cover
1.3d
Change
-95.4K sh
View
Short Volume
Short vol %
23%
As of
Aug 21, 2026
Short Total
View
Fails to Deliver
FTD shares
3.3K
Value
$1.4K
As of
Jul 31, 2026
View
Off-Exchange
Off-exchange %
66.6%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$2.0M
Net income (FY)
$-3.7M
EPS diluted
$-0.76
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 19, 2026
This year
14
View
Exempt Offerings
Offering
$3.0M
Filed
Feb 26, 2025
View
Earnings & Events
Earnings Calls
Last call
Mar 31, 2026
View

Performance

5D 20D 120D MTD YTD
AIDX +0.8% +13.1% -83.7% +28.9% —
SPY -1.4% +3.6% +11.6% +2.5% +12.3%
vs SPY +2.2% +9.5% -95.2% +26.4% —
Key facts CIK 1139685 CUSIP 90138K101 13F (30d) 14 filings 14 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)